The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples.
Van Paemel R, Vandeputte C, Raman L, Van Thorre J, Willems L, Van Dorpe J, Van Der Linden M, De Wilde J, De Koker A, Menten B, Devalck C, Vicha A, Grega M, Schleiermacher G, Iddir Y, Chicard M, van Zogchel L, Stutterheim J, Lak NSM, Tytgat GAM, Laureys G, Speleman F, De Wilde B, Lammens T, De Preter K, Van Roy N.
Van Paemel R, et al. Among authors: van zogchel l.
Eur J Cancer. 2022 Jan;160:12-23. doi: 10.1016/j.ejca.2021.09.022. Epub 2021 Nov 16.
Eur J Cancer. 2022.
PMID: 34794856
Free article.